Passage Bio Inc. shares PASG, +22.39% soared 19% in their trading debut Friday, after an initial public offering that priced at the top end of the $16 to $18 price range. Despite the turmoil in the market this week, the company upsized the deal to 12 million shares from 10 million, raising $216 million. Proceeds will be used to fund clinical development of therapies for rare, monogenic central nervous system disorders.
#div-gpt-ad-1569967089584-0 > div > iframe { width: 100% !important; min-width: 300px; max-width: 800px; }
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Pelosi: Stock market’s plunge is ‘disturbing,’ Trump ‘silly’ to pin fall on Democratic debateHouse Speaker Nancy Pelosi on Thursday expressed concern about the stock market’s coronavirus-driven selloff and the California Democrat also criticized President Donald Trump’s analysis of the market’s action. Nobody cares what that American hating woman thinks! How this woman is still in charge is amazing. Dems have many issues. She should go talk to “silly” gundlach then
続きを読む »
Here's the pitch deck that convinced Oliver Wyman's founder to back Trad3r - Business InsiderGaming app Trad3r lets users play a simulated stock market in real-time. We got a look at the pitch deck that convinced the founder of $2 billion consultancy Oliver Wyman to invest.
続きを読む »